Butler, Phillipe
Pascheto, Isabella
Lizzi, Michayla
St-Onge, Renée
Lanner, Carita
Guo, Baoqing
Masilamani, Twinkle
Pritzker, Laura B.
Kovala, A. Thomas
Parissenti, Amadeo M.
Funding for this research was provided by:
Natural Sciences and Engineering Research Council of Canada
MITACS
Northern Cancer Foundation, Sudbury
Rna Diagnositcs, Inc.
Northern Ontario School of Medicine Faculty Association Research Development Award Program
Article History
Received: 9 April 2022
Accepted: 23 January 2023
First Online: 31 January 2023
Competing interests
: Members of the team disclose the following significant conflicts of interest. A.M.P. holds significant shares in Rna Diagnostics, a company that is commercializing the RDA for clinical use. He also serves as the company’s Chief Scientific Officer. L.B.P., R.S., and T.M. are or were employees of Rna Diagnostics, and a significant portion of B.G.’s salary was supported by Rna Diagnostics during this investigation. A.M.P. and B.G. have and will receive royalties from the commercialization of the RDA. None of the remaining authors/team members have competing interests to disclose.